(Q22306225)

PubMed

PubMed publication ID

10782361

Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial

10 April 2023

language of work or name

English

0 references

publication date

April 2000

0 references

published in

Endocrine Reviews

0 references

volume

21

0 references

issue

2

0 references

page(s)

115-137

0 references

cites work

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Cell signaling and estrogens in female rat osteoblasts: a possible involvement of unconventional nonnuclear receptors

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Calcitonin receptor isoforms in mouse and rat osteoclasts

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Guanine nucleotide binding-protein coupled signaling pathway regulation of osteoblast-mediated bone formation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Function of osteocytes in bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Role of active and latent transforming growth factor beta in bone formation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Calcitonin alters behaviour of isolated osteoclasts

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Rapid activation of MAP kinase by estrogen in the bone cell line

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF)

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Effects of 17beta-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Evidence for two distinct syndromes of involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The alphas, betas, and kinases of cytokine receptor complexes

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Relationship between estrogen structure and conformational changes in estrogen receptor/DNA complexes

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Marrow stromal (Western-Bainton) cells: identification, morphometry, confocal imaging and changes in disease

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Regulation of osteoclast activity

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Phenolic A ring requirement for the neuroprotective effects of steroids

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Hormonal regulation of osteoclast function

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

PTHrP(1-36) as a skeletal anabolic agent for the treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The function of adipocytes in the bone marrow stroma: an update

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Identification of apoptotic changes in osteocytes in normal and pathological human bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Cytokines, bone remodeling, and estrogen deficiency: a 1998 update

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Effects of estradiol-17 beta analogues on activation of estrogen response element regulated chloramphenicol acetyltransferase expression

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased bone formation in osteocalcin-deficient mice.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Nontraumatic necrosis of bone (osteonecrosis).

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Effect of testosterone and estradiol in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Competition between noggin and bone morphogenetic protein 4 activities may regulate dorsalization during Xenopus development

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Dissociation between bone resorption and bone formation in osteopenic transgenic mice

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroi

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Alkaline phosphatase positive precursors of adipocytes in the human bone marrow

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

1 reference

7 January 2021

The role of IL-6 type cytokines and their receptors in bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Trafficking of Matrix Collagens Through Bone-Resorbing Osteoclasts

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Removal of osteoclast bone resorption products by transcytosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Mechanisms and genes of cellular suicide

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Developmental abnormalities in mice transgenic for bovine oncostatin M.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Apoptosis in bone physiology and disease

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Interleukin-11: a new cytokine critical for osteoclast development

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Stemming bone loss by suppressing apoptosis.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

1 reference

7 January 2021

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

In vivo distribution of parathyroid hormone receptors in bone: evidence that a predominant osseous target cell is not the mature osteoblast

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Platelet-derived growth factor stimulates the synthesis of interleukin-6 in cells of the osteoblast lineage

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34).

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Murine bone marrow stromally derived BMS2 adipocytes support differentiation and function of osteoclast-like cells in vitro

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Inhibitory actions of glucocorticoids on skeletal growth. Is local insulin-like growth factor I to blame?

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Cell number versus cell vigor--what really matters to a regenerating skeleton?

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Glucocorticoid effects on bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Latent forms of transforming growth factor-beta (TGF beta) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGF beta

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Regulation of osteoclast function

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Relationship of bone turnover to bone density and fractures

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Quantitative Trait Loci Affecting Peak Bone Mineral Density in Mice

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Bone density and fracture risk in men.

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Reply : unitary model of osteoporosis revisited

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

The Role of Estrogen in the Control of Rat Osteocyte Apoptosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

New developments in the pathogenesis and treatment of steroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Identification of mammalian noggin and its expression in the adult nervous system

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Control of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Matrix proteins and mineralization: an overview

1 reference

https://api.crossref.org/works/10.1210%2FEDRV.21.2.0395

7 January 2021

Identifiers

DOI

10.1210/EDRV.21.2.0395

0 references

10.1210/ER.21.2.115

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10782361

1 reference

Consolidated OpenCitations Corpus – April 2017